DRKS00008988已完成未知
Selective depletion of C-reactive protein by therapeutic apheresis (CRP-apheresis) in acute myocardial infarction
Pentracor GmbH0 个研究点目标入组 83 人开始时间: 2015年8月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 83
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •STEMI as defined by the guidelines of the European Society of Cardiology (ESC) for the treatment of AMI in patients with ST-segment elevation.
- •TIMI III flow after PCI (stent implantation)
- •Killip-Class = II
- •2 - 12 h from onset of symptoms until coronary reperfusion
- •Informed consent
- •Legal competence
排除标准
- •Previous myocardial infarction
- •Acute infectious disease (body temperature (auricular, sublingual) > 38.0 °C)
- •Systolic blood pressure < 100 mmHg
- •Known hypersensitivity to therapeutic apheresis
- •Cardiogenic shock
- •Dialysis dependent renal insufficiency
- •Previous coronary artery bypass surgery
- •Contraindication for MRI (e.g. non-MRI-capable implants, claustrophobia)
- •Malignant or chronic inflammatory disease
- •Pregnancy or lactation period
- •Limited possibility to join the follow-up examination (e.g., patient lives abroad)
- •Participation in other interventional trials
研究者
相似试验
招募中
不适用
Selective depletion of C-reactive protein by therapeutic apheresis (CRP apheresis) in Crohn's disease and ulcerative colitisUlcerative colitisK50K51Crohn disease [regional enteritis]DRKS00015460Pentracor GmbH20
已完成
不适用
Selective depletion of the C-reactive protein by means of therapeutic CRP apheresis to reduce myocardial damage after coronary bypass surgeryI25Chronic ischaemic heart diseaseDRKS00013012Pentracor GmbH44
招募中
不适用
Selective depletion of C-reactive protein by means of therapeutic apheresis (CRP-apheresis) in acute pancreatitisK85.80DRKS00014265Pentracor GmbH20
进行中（未招募）
Unknown
Effectiveness of C-reactive protein testing for optimising antibiotic treatment in neonates and children in Zanzibareonates at risk of early onset sepsis, admitted neonates (0-28 days) with clinical signs of sepsis and admitted children (6 months to 12 years) with febrile illness or diarrheaInfections and InfestationsISRCTN25937092International Centre for Antimicrobial Resistance Solutions (ICARS)2,261
尚未招募
Unknown
Does hs-CRP predict the severity of cardiovascular disease and chronic kidney disease?CTRI/2023/03/050262MANIPAL ACADEMY OF HIGHER EDUCATIO